Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis \(AD\)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07194408
What this trial is testing

In-Use Tolerance Study Under Dermatological and Pediatric Controls of Sunscreen in Children With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)SCORAD Index (15-25)
Pierre Fabre Dermo Cosmetique 22
Not applicableNot Yet RecruitingNCT07813611
What this trial is testing

Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)ScabiesImpetigo
Istanbul Medeniyet University 51
Not applicableStudy completedNCT07839897
What this trial is testing

EFFICACY AND TOLERANCE OF AN EMOLLIENT CREAM IN SKIN OF COLOR

Who this might be right for
Atopic Dermatitis (AD)
Pierre Fabre Dermo Cosmetique 59
Testing effectiveness (Phase 2)Looking for participantsNCT07441395
What this trial is testing

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Who this might be right for
Atopic DermatitisAtopic Dermatitis EczemaEczema+1 more
Corvus Pharmaceuticals, Inc. 200
Early research (Phase 1)Looking for participantsNCT07558668
What this trial is testing

A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Sitryx Therapeutics Ltd 149
Not applicableNot Yet RecruitingNCT07448363
What this trial is testing

Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica

Who this might be right for
Atopic DermatitisAtopic Dermatitis (AD)Atopic Dermatitis (Eczema)+3 more
Caja Costarricense de Seguro Social 50
Early research (Phase 1)Active Not RecruitingNCT07027527
What this trial is testing

An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Apogee Therapeutics, Inc. 86
Testing effectiveness (Phase 2)Study completedNCT01979016
What this trial is testing

Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis (AD)
Regeneron Pharmaceuticals 54
Not applicableStudy completedNCT07009483
What this trial is testing

Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes

Who this might be right for
Atopic Dermatitis (AD)
University of Alberta 57
Not applicableLooking for participantsNCT07021495
What this trial is testing

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

Who this might be right for
Chronic Spontaneous Urticaria (CSU)Hidradenitis Suppurativa (HS)Psoriasis (PsO)+2 more
Leiden University Medical Center 840
Large-scale testing (Phase 3)Study completedNCT03269773
What this trial is testing

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 197
Large-scale testing (Phase 3)Active Not RecruitingNCT06241118
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

Who this might be right for
Dermatitis Atopic
Sanofi 464
Testing effectiveness (Phase 2)Looking for participantsNCT07230483
What this trial is testing

A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis (AD)
Keymed Biosciences Co.Ltd 246
Not applicableLooking for participantsNCT07659756
What this trial is testing

Global Healthcare Study on Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)Atopic Dermatitis (Eczema)
Julia Tatjana Maul 9,600
Testing effectiveness (Phase 2)Active Not RecruitingNCT06136741
What this trial is testing

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Nektar Therapeutics 396
Testing effectiveness (Phase 2)Looking for participantsNCT06931990
What this trial is testing

Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. 24
Not applicableActive Not RecruitingNCT05139836
What this trial is testing

Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting

Who this might be right for
Atopic Dermatitis
AbbVie 634
Not applicableActive Not RecruitingNCT05669794
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World

Who this might be right for
Atopic Dermatitis
AbbVie 300
Early research (Phase 1)Study completedNCT07329101
What this trial is testing

Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Jiangsu vcare pharmaceutical technology co., LTD 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT06996912
What this trial is testing

HSK44459 in Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Xizang Haisco Pharmaceutical Co., Ltd 150
Next Page